The San Antonio Spurs have teamed up with Sanofi US, a diversified global healthcare leader, to create a program to help bring awareness for diabetes among both children and adults.
Spurs forward Stephen Jackson will serve as a diabetes awareness spokesperson for the campaign, which tips-off today in the fight against diabetes by encouraging basketball fans to take the pledge to become a Healthy Lifestyles Ambassador.
Every 17 seconds another American is diagnosed with diabetes, and by taking a pledge to become a Healthy Lifestyles Ambassador with the Partner Up for Diabetes Awareness program, you are pledging to live an active, healthy lifestyle and raise awareness about diabetes risk reduction and management.
Those that take the pledge on http://www.nba.com/spurs/Sanofi are automatically entered into the Suite Life for the Spurs Sweepstakes, where you could win a suite night at the Diabetes Alert Day Spurs Game March 27 and a meet and greet with Stephen Jackson.
“Sanofi is committed to serving as a valued partner to the diabetes community,” said Dennis Urbaniak, Vice President, Head of U.S. Diabetes, Sanofi US. “By partnering with the Spurs through the Sanofi US and San Antonio Spurs Team Up For Diabetes Awareness program, we will be able to reach basketball fans and raise awareness about diabetes risk reduction and management.”
The San Antonio Spurs Diabetes Alert Day Game on March 27 will feature on-court promotions, in-game diabetes awareness education and an on-court presentation honoring fans living with diabetes. Additionally, attendees throughout Spurs Holiday Youth Basketball camps and Silver Dancer Clinics will learn about what it means to live a healthy lifestyle and how they can reduce their risk of diabetes
In 2010, nearly 10% of the people in Texas were diagnosed with diabetes*. Cases of diabetes are skyrocketing and nearly 26 million Americans are living with the disease. The American Diabetes Association has estimated 50 million Americans will have diabetes by 2025.
While diabetes is prevalent, widespread ignorance and misconception about the disease and the medications available to treat it continue to affect how people react to diagnosis and management, whether or not they are living with the disease.